Article thumbnail

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

By Stewart J. Tepper, Shashidhar H. Kori, Peter J. Goadsby, Paul K. Winner, Min H. Wang, Stephen D. Silberstein and F. Michael Cutrer


OBJECTIVE: To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamine, for acute treatment of migraine when administered at various time points from within 1 hour to more than 8 hours after migraine onset

Topics: Original Articles
Publisher: Mayo Foundation for Medical Education and Research
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles